Optimi Health

OPTH · CANADIAN

$3.25−$0.03 (−0.91%)TodayMarket closed ·
Prev close $3.28

About OPTH

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.

Employees
9
Headquarters
Vancouver, British Columbia
Listed
Feb 25, 2021
Sector
N/A
Industry
N/A

Leadership

Optimi Health executives
NameTitleSince
James Wilson——
Dane Stevens—2020
Jacob Safarik—2020
Bryan Safarik—2020
Jonathan Schintler——

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.